INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

NAGENiagen Bioscience, Inc.

CIK 0001386570

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells2 / 0
Max Insider Score41
Connections7with evidence

NAGE · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
NG
Ng Wang Yu GaryDirector
NAGENiagen Bioscience, Inc.
Grant or award
A—
31.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2833 · Medicinal Chemicals & Botanical Products · Nov 4, 2026
  • ← Insider ofevidence
    Cohen AnnDirector · Jun 26, 2026
  • ← Insider ofevidence
    Ng Wang Yu GaryDirector · Jun 26, 2026
  • ← Insider ofevidence
    Shahbazi HamedDirector · Jun 26, 2026
9
SH
Shahbazi HamedDirector
NAGENiagen Bioscience, Inc.
Grant or award
A
—
31.7K sh
Jun 24, 2026
Jun 26, 2026
traded Jun 24, 2026
+2d
SEC FORM 4

Evidence

9
CA
Cohen AnnDirector
NAGENiagen Bioscience, Inc.
Grant or award
A—
31.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

9
PK
Patrick KristinDirector
NAGENiagen Bioscience, Inc.
Grant or award
A—
31.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

9
YW
YU Wing Tak WendyDirector
NAGENiagen Bioscience, Inc.
Grant or award
A—
31.7K sh
Jun 24, 2026Jun 26, 2026
traded Jun 24, 2026
+2dSEC FORM 4

Evidence

41
PO
Pamir OzanChief Financial Officer
NAGENiagen Bioscience, Inc.
Open-market purchase
BUY$30K
4,465 sh
Nov 14, 2025Nov 17, 2025
traded Nov 14, 2025
+3dSEC FORM 4

Evidence

41
PO
Pamir OzanChief Financial Officer
NAGENiagen Bioscience, Inc.
Open-market purchase
BUY$15K
2,220 sh
Nov 14, 2025Nov 17, 2025
traded Nov 14, 2025
+3dSEC FORM 4

Evidence

← Insider ofevidence
YU Wing Tak Wendy
Director · Jun 26, 2026
  • ← Insider ofevidence
    Patrick KristinDirector · Jun 26, 2026
  • ← Insider ofevidence
    Pamir OzanChief Financial Officer · Nov 17, 2025